QIM
GSK icon

Quantitative Investment Management’s GSK GSK Stock Holding History

Quantitative Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,645
Closed -$286K – 451
2025
Q3 		$286K Buy
+6,645
New +$260K 0.04% 281
2024
Q1 		– Sell
-7,923
Closed -$293K – 301
2023
Q4 		$293K Sell
7,923
-42,782
-84% -$1.54M 0.02% 302
2023
Q3 		$1.84M Buy
+50,705
New +$1.8M 0.28% 77
2023
Q2 		– Sell
-25,414
Closed -$904K – 299
2023
Q1 		$904K Buy
+25,414
New +$889K 0.19% 124
2020
Q2 		– Sell
-92,688
Closed -$4.39M – 578
2020
Q1 		$4.39M Buy
+92,688
New +$4.94M 0.48% 40
2019
Q4 		– Sell
-190,783
Closed -$10.2M – 683
2019
Q3 		$10.2M Buy
190,783
+105,201
+123% +$5.41M 0.54% 33
2019
Q2 		$4.28M Buy
85,582
+8,302
+11% +$417K 0.17% 160
2019
Q1 		$4.04M Buy
+77,280
New +$3.86M 0.23% 122
2017
Q3 		– Sell
-59,760
Closed -$3.22M – 745
2017
Q2 		$3.22M Buy
+59,760
New +$3.19M 0.05% 421
2016
Q4 		– Sell
-104,320
Closed -$5.62M – 849
2016
Q3 		$5.62M Buy
+104,320
New +$5.72M 0.19% 132
2016
Q2 		– Sell
-60,320
Closed -$3.06M – 818
2016
Q1 		$3.06M Buy
+60,320
New +$3M 0.15% 169
2015
Q2 		– Sell
-12,000
Closed -$692K – 553
2015
Q1 		$692K Buy
+12,000
New +$688K 0.07% 272
2014
Q4 		– Sell
-11,440
Closed -$657K – 525
2014
Q3 		$657K Buy
+11,440
New +$701K 0.13% 141
2014
Q2 		– Sell
-8,080
Closed -$539K – 537
2014
Q1 		$539K Buy
8,080
+4,000
+98% +$270K 0.03% 342
2013
Q4 		$272K Buy
+4,080
New +$265K 0.03% 449
2013
Q3 		– Sell
-30,880
Closed -$1.93M – 578
2013
Q2 		$1.93M Buy
+30,880
New +$1.96M 0.34% 56

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quantitative Investment Management's GSK Position: Q4 2025 in Review

Quantitative Investment Management sold out of GSK (GSK) in Q4 2025, closing a stake of 6,645 shares — an estimated $286K sold.

Quantitative Investment Management first reported a position in GSK in Q2 2013 and held it in 16 quarters. The position peaked at $10.2M in Q3 2019. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • Quantitative Investment Management reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
  • Quantitative Investment Management sold 6,645 GSK shares in Q4 2025, an estimated $286K.
  • Quantitative Investment Management first reported a position in GSK in Q2 2013 and held it in 16 quarters.
  • Quantitative Investment Management's GSK position peaked at $10.2M in Q3 2019.
  • 995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Quantitative Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.